1. Home
  2. Research
  3. Research Groups
  4. Infectious Diseases

Infectious Diseases

Search for publications

Only original articles, editorials, guidelines.

  • Cuervo G, Camoez M, Shaw E, Dominguez MÁ, Gasch O, Padilla B, Pintado V, Almirante B, Molina J, López-Medrano F, Ruiz de Gopegui E, Martinez JA, Bereciartua E, Rodriguez-Lopez F, Fernandez-Mazarrasa C, Goenaga MÁ, Benito N, Rodriguez-Baño J, Espejo E, Pujol M.

    Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients

    BMC INFECTIOUS DISEASES . 15(1): 484-484. Number of citations: 3

    [doi:10.1186/s12879-015-1227-y]

  • Palladino C, Gómez ML, Soler-Palacín P, González-Tomé MI, De Ory SJ, Espiau M, Hoyos SP, León-Leal JA, Méndez M, Moreno-Pérez D, Guasch CF, Sierra AM, Guruceta IP, Guillén SM, Briz V.

    Off-label use of maraviroc in HIV-1-infected paediatric patients in clinical practice

    AIDS . 29(16): 2155-2159. Number of citations: 3

    [doi:10.1097/QAD.0000000000000819]

  • Treviño A, Caballero E, de Mendoza C, Aguilera A, Pirón M, Soriano V.

    The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain

    AIDS REVIEWS . 17(4): 212-219. Number of citations: 10

  • Muñoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, Fariñas MC, Cobo Belaustegui M, Mestres C, Llinares P, Goenaga M, Navas E, Oteo JA, Tarabini P, Bouza E.

    Current Epidemiology and Outcome of Infective Endocarditis A Multicenter, Prospective, Cohort Study

    Medicine . 94(43): . Number of citations: 76

    [doi:10.1097/MD.0000000000001816]

  • Navas E, Torner N, Broner S, Godoy P, Martínez A, Bartolomé R, Domínguez A.

    Economic costs of outbreaks of acute viral gastroenteritis due to norovirus in Catalonia (Spain), 2010-2011

    Bmc Public Health . 15(1): 999-999. Number of citations: 13

    [doi:10.1186/s12889-015-2289-x]

  • García Comas L, Ordobás Gavín M, Sanz Moreno JC, Ramos Blázquez B, Gutiérrez Rodríguez A, Astray Mochales J, Moreno Guillén S.

    Prevalence of hepatitis C antibodies in the population aged 16-80 years in the Community of Madrid 2008-2009.

    JOURNAL OF MEDICAL VIROLOGY . 87(10): 1697-1701. Number of citations: 22

    [doi:10.1002/jmv.24219]

  • San-Juan R, Navarro D, García-Reyne A, Montejo M, Muñoz P, Carratala J, Len O, Fortun J, Muñoz-Cobo B, Gimenez E, Eworo A, Sabe N, Meije Y, Martín-Davila P, Andres A, Delgado J, Jimenez C, Amat P, Fernández-Ruiz M, López-Medrano F, Lumbreras C, Aguado JM, REIPI Network.

    Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D plus /R- solid organ transplant recipients

    TRANSPLANT INFECTIOUS DISEASE . 17(5): 637-646. Number of citations: 15

    [doi:10.1111/tid.12417]

  • de Egea V, Muñoz P, Valerio M, de Alarcón A, Lepe JA, Miró JM, Gálvez-Acebal J, García-Pavía P, Navas E, Goenaga MA, Fariñas MC, Vázquez EG, Marín M, Bouza E.

    Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century A Systematic Review of 111 Cases (2000-2013)

    Medicine . 94(39): . Number of citations: 33

    [doi:10.1097/MD.0000000000001562]

  • Blanco JR, Arroyo-Manzano D, Rojas-Liévano JF, Crespo M, Bravo I, Pasquau J, Garcia Del Toro M, Herrero C, Rivero A, Moreno S, Llibre JM.

    The Efficacy and Safety of Maraviroc Addition to a Stable Antiretroviral Regimen in Subjects with Suppressed Plasma HIV-RNA Is Not Influenced by Age

    AIDS RESEARCH AND HUMAN RETROVIRUSES . 31(9): 893-897. Number of citations: 4

    [doi:10.1089/aid.2015.0016]

  • Falcon A, Cuevas MT, Rodriguez-Frandsen A, Reyes N, Pozo F, Moreno S, Ledesma J, Martínez-Alarcón J, Nieto A, Casas I.

    CCR5 deficiency predisposes to fatal outcome in influenza virus infection

    JOURNAL OF GENERAL VIROLOGY . 96(8): 2074-2078. Number of citations: 42

    [doi:10.1099/vir.0.000165]

  • Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HIV-CAUSAL Collaboration.

    Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

    LANCET HIV . 2(8): 335-343. Number of citations: 37

    [doi:10.1016/S2352-3018(15)00108-3]

  • Llibre JM, Rivero A, Rojas JF, Garcia Del Toro M, Herrero C, Arroyo D, Pineda JA, Pasquau J, Masiá M, Crespo M, Blanco JR, Moreno S.

    Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes

    ANTIVIRAL RESEARCH . 120: 79-84. Number of citations: 11

    [doi:10.1016/j.antiviral.2015.05.001]

  • Díaz L, Martínez-Bonet M, Sánchez J, Fernández-Pineda A, Jiménez JL, Muñoz E, Moreno S, Álvarez S, Muñoz-Fernández MÁ.

    Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-kappa B-dependent mechanism

    SCIENTIFIC REPORTS . 5: 12442-12442. Number of citations: 44

    [doi:10.1038/srep12442]

  • Schultze A, Phillips AN, Paredes R, Battegay M, Rockstroh JK, Machala L, Tomazic J, Girard PM, Januskevica I, Gronborg-Laut K, Lundgren JD, Cozzi-Lepri A, EuroSIDA in EuroCOORD.

    HIV resistance testing and detected drug resistance in Europe

    AIDS . 29(11): 1379-1389. Number of citations: 12

    [doi:10.1097/QAD.0000000000000708]

  • Martínez-Bonet M, Clemente MI, Serramía MJ, Moreno S, Muñoz E, Muñoz-Fernández MA.

    Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells::a possibility for HIV-1 paediatric patients?

    Journal of virus eradication . 1(3): 148-152. Number of citations: 4

  • May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, Neau D, Guiguet M, Schwarze-Zander C, Moreno S, Guest JL, Monforte Ad, Tural C, Gill MJ, Bregenzer A, Kirk O, Saag M, Sterling TR, Crane HM, Sterne JA.

    Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 69(3): 348-354. Number of citations: 34

    [doi:10.1097/QAI.0000000000000603]

  • Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, OLE/RIS-EST13 Study Group.

    Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

    LANCET INFECTIOUS DISEASES . 15(7): 785-792. Number of citations: 121

    [doi:10.1016/S1473-3099(15)00096-1]

  • Aldámiz-Echevarría T, González-García J, Von Wichmann MA, Crespo M, López-Aldeguer J, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Bellón JM, Montes M, Berenguer J.

    Association of baseline CD4+cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients

    ANNALS OF HEPATOLOGY . 14(4): 464-469. Number of citations: 1

    [doi:10.1016/S1665-2681(19)31167-6]